InterSol is a Intravenous Solution in the Human Prescription Drug category. It is labeled and distributed by Fenwal, Inc.. The primary component is Sodium Chloride; Sodium Acetate; Trisodium Citrate Dihydrate; Sodium Phosphate, Dibasic; Sodium Phosphate, Monobasic, Monohydrate.
Product ID | 0942-9601_1b5f88e6-25c8-4ce5-a074-500995aad6ef |
NDC | 0942-9601 |
Product Type | Human Prescription Drug |
Proprietary Name | InterSol |
Generic Name | Platelet Additive 3 |
Dosage Form | Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2012-10-25 |
Marketing Category | NDA / NDA |
Application Number | BN080041 |
Labeler Name | Fenwal, Inc. |
Substance Name | SODIUM CHLORIDE; SODIUM ACETATE; TRISODIUM CITRATE DIHYDRATE; SODIUM PHOSPHATE, DIBASIC; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE |
Active Ingredient Strength | 452 mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL |
Pharm Classes | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2012-10-25 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | BN080041 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-10-25 |
Ingredient | Strength |
---|---|
SODIUM CHLORIDE | 452 mg/100mL |
SPL SET ID: | e4f06c0b-7cb1-49c9-97a4-2cfc21298495 |
Manufacturer | |
UNII |
NDC | Brand Name | Generic Name |
---|---|---|
0942-9601 | InterSol | Platelet Additive 3 |
0942-9602 | InterSol | Platelet Additive 3 |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
INTERSOL 77930716 not registered Dead/Abandoned |
Fenwal, Inc. 2010-02-08 |
INTERSOL 77264583 not registered Dead/Abandoned |
Components For Automation, Inc. 2007-08-26 |
INTERSOL 76077081 2753566 Live/Registered |
Fenwal, Inc. 2000-06-22 |